We will beat childhood cancer
by using novel research, precision medicine, innovative clinical trials, and collaboration across the globe to help children with difficult to treat solid tumors.
The Beat Childhood Cancer Research Consortium is a group of 50+ universities and children’s hospitals that offer a worldwide network of childhood cancer clinical trials. These trials are based on the research from a group of closely collaborating investigators who are linked with laboratory programs developing novel therapies for high-risk pediatric cancers. Our mission is to continue to use precision medicine and immunotherapy to bring forward new therapies for children with cancer with the goal of finding a cure for all patients.
Clinical Trials
Clinical Trials for children battling childhood cancer. Our focus is on novel therapies for difficult to treat relapsed and refractory cancers.
Precision Medicine
Instead of treating cancer by its name/diagnosis, treating it by specific targets through genomic sequencing.
Preclinical Research
Research is often thought of as being decades away from the clinic, but here, the work is actively helping patients today.
“I am proud of the BCC Research Consortium and our goal to serve every child, everywhere.
The children and families we see are the true heroes who motivate us to work harder and inspire hope.”
Dr. Giselle Saulnier Sholler,
BCC Research Consortium Founder and Chair
